Home/Publication/IDG & Shenzhen Capital to Advance Vaccine Development
IDG & Shenzhen Capital to Advance Vaccine Development 

03 Nov 2025

US$ 20.00

IDG Capital (IDG), Shenzhen Capital Group Co Ltd and Ruipu Pharma have invested over Rmb400 m (US$56.3 m) in the ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly ending 22 May 2026...

Once largely discreet and illusive in the private capital markets outside of their domains, they are now among the ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.